A look at the LC and LC–MS methods that are helping to overcome challenges in sample analysis, and how this can make adeno‑associated virus (AAV)–based gene therapy more accessible.
Ximo Zhang
Advertisement
Ximo Zhang is a Senior Scientist at Waters Corporation in Milford, Massachusetts, USA.
Articles by Ximo Zhang
Recombinant adeno-associated viral therapy (rAAV) products are particularly complex. Are liquid chromatography and LC–MS the right tools for their characterization?
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on LCGC International
1
Fast Low-Pressure Chiral GC for Pesticides in Wine
2
Industry Roundup: Air Products Advances Gas Chromatography Performance
3
AI/ML Now: Hybrid Machine Learning for Experiment-Efficient HPLC
4
AI/ML Now: Bringing Autonomous Digital Twin Workflows Into the Laboratory
5